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ABSTRACT 
 
Incorporation of Analgesics into Rodent Embryo Transfer Protocols:   
Assessing the Effects on Reproductive Outcomes.  (December 2006) 
Heather Ann Burckhardt, B.S., Texas A&M University 
Chair of Advisory Committee:  Dr. Melanie M. Ihrig 
 
 
 Surgical embryo transfer in rodents is a common procedure in today’s research 
laboratory, although little is known of the effect analgesics may have on not only the 
recipient female but also the embryos.  Two perioperative analgesics, ketoprofen and 
buprenorphine, were evaluated against a saline control in terms of number of pups born, 
number of pups weaned, and whether or not a litter was born.  Both a uterine approach 
and an oviduct approach were evaluated.  Post-surgical behavior was compared among 
the three surgical animals in each group, and between the non-surgical analgesic control 
and its surgical counterpart.  Results indicated that ketoprofen and buprenorphine have 
no effect on the number of pups born, weaned, or litters born when compared to a saline 
control.  Significant differences were found between the non-surgical analgesic control 
and its surgical counterpart in two behavioral categories; once for ketoprofen (behavior) 
and once for buprenorphine (physical condition).  No other differences were found. 
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This thesis follows the style of Comparative Medicine. 
 
1. INTRODUCTION 
1.1 HISTORY 
 
The procedure of transferring embryos from one female to a second recipient female 
is one that has been around for at least a century.  Walter Heape performed the first 
successful experiment in 1890.  In this groundbreaking procedure, he took fertilized eggs 
from an Angora rabbit and placed them within the fallopian tube of a bred Belgian doe.  
The Belgian doe eventually gave birth to six kits, two of which were “undoubted 
Angoras” in Heape’s own words.  This original experiment was conceived to determine 
what effect a  recipient foster-mother would have on the implanted embryos.  Its second 
goal was to determine what effect the presence of foreign embryos in the uterus would 
have on the native offspring of the recipient female (18).   
Since that particular experiment, there have been many other noteworthy and 
successful attempts using the mouse as the experimental animal.  The first such 
published successful attempt was by Bittner and Little in 1937.  This was followed by 
subsequent publications by Fekete and Little in 1942, Fekete in 1947, Beatty in 1951, 
Runner in 1951, Runner and Palm in 1953, and Boot and Muehlbock in 1953.  It was 
Runner and Palm in 1953 who discovered and published the technique used today of 
inducing ovulation in the mice via the injection of hormones (18, 1, 19). 
The next major landmark in the history of embryo transfer occurred in 1956, with a 
paper written by Anne McLaren and Donald Mitchie entitled “Studies on the Transfer of 
Fertilized Mouse Eggs to Uterine Foster-Mothers.”  This paper, published by the Journal 
of Experimental Biology, outlined a massive experimental undertaking in which many 
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questions that had arisen since the first transfer in 1890 were addressed.  Some of the 
areas of interest included the effect of foreign ova on the recipient female herself; the 
timing of coitus between the donors and the recipients; the possibility of an “ideal” 
number or a “ceiling” to the number of eggs that could be implanted per uterine horn; 
the effect the foreign embryos had on the native ones; the effect surgical trauma had on 
the recipient female; and the sexual maturity of the donors (18). 
Through the work of McLaren and Michie it was determined that immature, induced-
ovulation female donors at 3.5 days post-coitus (dpc) at surgery and recipients at 2.5 dpc 
yielded the most successful results (18).  This particular combination gave nearly twice 
the yield of live, full-term young as compared to the other time-point combinations.  
These findings have been incorporated into embryo transfer protocols and are still used 
today (7, 1, 28, 12, 16, 17).  Recipient mice are mated a full day after the donors to 
ensure the proper uterine environment for the embryos. 
McLaren and Michie also studied the effect of surgery on the recipient mothers.  
They found no statistically significant difference between the groups of non-surgical 
pregnant control mice and the embryo transfer recipient mice that became pregnant (18).  
In “dummy” transfers, where saline without embryos was injected into the uterine horn 
of a pregnant recipient, the number of implanted embryos suffered.  It was thought that 
the saline flushed away the native embryos in the injected horn, resulting in a smaller 
number of implants.  Later experiments supported this view, as when the saline was 
loaded with foreign embryos the implantation number actually increased in the injected 
horn as compared to the uninjected one (18).   
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Their findings also took into account the effects of “traumatic” vs. “non-traumatic” 
operations, two subjective categories determined by the investigators themselves (18).  
Recipients at 3.5 dpc had an overall greater resorption rate, and that rate increased when 
subjected to a “traumatic” surgery.  In contrast, the 2.5 dpc recipients had the same rate 
of absorption whether the surgery was classified as traumatic or not.  However, severe 
trauma can result in post-implantational mortality even in 2.5 dpc recipients (18, 16). 
In pregnant recipient females, there is competition between “native” and “alien” 
embryos for implantation in the uterus (18).  This would explain the greater number of 
implanted foreign embryos in the injected horn:  at 3.5 dpc, the foreign embryos are 
further along in their development and ready to implant in a primed uterus.  The native 
embryos, only at 2.5 dpc, are not ready to implant and are shunted aside (18).  This 
series of experiments was repeated with pseudopregnant recipient females; in these 
operations nearly all of the eggs injected implanted, suggesting that there is competition 
between the native and alien embryos.  Most embryo transfers done today utilize a 
pseudopregnant female to ensure that as many injected embryos as possible implant (7, 
28, 12, 16).  A pseudopregnant female is one who has been bred to a vasectomized male.  
The male does not have the ability to impregnate the female, but due to the act of mating 
her body behaves as though she is pregnant.  This prepares the uterus to be more 
receptive to the injected embryos. 
A question addressed in these experiments was whether or not there was a maximum 
number of implants a uterine horn could cultivate.  Although there did not seem to be a 
maximum per horn, there was a ceiling on the total number of implants.  As long as the 
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total number of implants for both horns did not exceed this number, it did not matter 
how many implanted per side (18).  Researchers involved in transgenic mouse 
production inject many manipulated embryos into each uterine horn to maximize the 
number that implant and survive (16).  If too many implant, however, the rate of 
absorption in the uterine horn increases.  Trial and error must be used to determine the 
optimal number between introducing as many embryos as possible, and injecting so 
many that most are absorbed or the entire innoculum is lost (18).   
McLaren and Michie undertook this experiment with far-reaching goals in mind.  
They saw the potential this procedure had in research and practical applications in 
livestock and even humans as well.  In the introduction to their published work, in fact, 
they cite the “range of problems in genetics’ embryology, reproductive physiology, 
immunology and cancer research” that could be studied and perhaps even solved with 
the use of this new technique (18).  Applications to livestock were mentioned as well, 
describing a situation in which a sexually immature yet valuable female could be 
induced to ovulate, the eggs collected and fertilized in vitro, then either frozen for later 
use or transferred immediately into a sexually mature recipient female.  The same idea 
has been in practice for many years, in which artificial insemination is used to propagate 
the genetic superiority of a male (1, 6).  This would be a similar procedure, in which the 
genetics of a female could be passed on without even waiting for the female to become 
mature enough to bear her own young. 
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1.2 TARGETED MUTANT MOUSE PROJECT 
Little has changed in embryo transfer from the original research undertaken almost 
fifty years ago.  Laboratory manuals published on the subject cite the “extensive work” 
by McLaren and Mitchie as the basis for their surgical technique (14, 21).  The same 
technique developed in 1956 has been used in a variety of procedures, from producing 
germ-free mice, to clearing a colony of a persistent mouse hepatitis virus (MHV) 
infection, to creating new lines of transgenic animals, to reinstating a line after 
cryopreservation (4, 13, 23, 25, 2, 31, 20).       
In an interview in 1986, on the 30
th
 anniversary of her ground-breaking experiment, 
Ann McLaren stated that “there are certain procedures, such as injection of genes or 
nuclei into eggs, that in my view are too remote … to be … discussed at the present time 
(5).”  Just one year after McLaren’s pronouncement, a researcher by the name of Mario 
R. Capecchi was experimenting with that technique (3). 
In his paper, Capecchi talks of the vast amount of work spent on analyzing countless 
numbers of mutations when it was unknown “which mutations [were] worthy of detailed 
characterization (3).”  This premise has changed, Capecchi says, because the researcher 
no longer has to wait for random mutagenesis:  “Through gene targeting, the potential 
now exists to generate mice of any desired genotype (3).”  This method has far-reaching 
potential, from removing the functionality of a gene, to causing it to overexpress, to 
introducing genes from an entirely new species into a genome (8, 28).  Embryo transfer 
is of particular import to this endeavor.  It is through this procedure that the genetically 
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modified embryos are placed within a viable uterus in the hopes that they will develop 
into animals with the desired modification.   
Generally, there are two types of genetically modified mice.  The first is what is 
known as a transgenic mouse.  The transgenic mouse has a transgene, a gene taken from 
the genome of another organism and introduced into its own.  The purified DNA 
containing the transgene is injected into the pronucleus of a fertilized 1-cell egg, called a 
zygote.  This insertion results in stable germline transmission of the microinjected DNA 
around 1% of the time.  The egg is then transferred into a pseudopregnant recipient 
female.  The transgene is integrated randomly and transmits as a “Mendelian trait”, 
which is one that segregates in accordance with the laws of genetics set forth by Gregor 
Mendel (29).  Germ-line founder mice, those in whom the transgene integrated into their 
germ cells, are bred to produce the transgenic line (29, 28).  The advantage of this 
method is that there are no size limitations on the transgene (28).  The disadvantage, as 
stated before, is that the insertion integrates randomly into the genome:  the researcher 
has no control over where it goes (29, 28).  This random insertion may occur in the midst 
of a functionally important gene, thereby disrupting it and producing an unexpected and 
possibly undesirable phenotype. 
The second type of genetically modified mouse is the targeted mutant, commonly 
known as the “knockout” mouse (28).  In these animals, “specific endogenous genes 
have been disrupted and rendered inactive by insertion of nonfunctional exogenous DNA 
sequences (28).”  These mice are created using embryonic stem (ES) cells derived from 
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mouse blastocysts.  These cells were first cultured in 1981 by Drs. M. Evans and G. 
Martin (28).  ES cells are pluripotent, meaning they can develop into any type of tissue.   
In brief, the procedure for creating genetically modified ES cells follows.  
Blastocysts from superovulated donor mice are harvested and the inner cell mass is 
removed and placed in culture.  A DNA construct is then introduced to the ES cell 
culture.  “Typically, a targeting vector is designed” that utilizes a “positive selectable 
marker such as the neo’ gene” which confers resistance to the drug neomycin (28).  
Since the neo’ gene is placed in the middle of the construct, integration will confer the 
drug resistance.  When neomycin is introduced into the media, the cells which have not 
integrated the construct are killed.  A second selective method is one that involves a 
negative selective factor, such as one that makes the cells sensitive to the drug 
gancyclovir, placed at the end of the construct.  If the construct is integrated correctly, 
the part containing the sensitivity will be eliminated during homologous recombination.  
If the construct is integrated randomly, the selection factor will be maintained and the 
cells will die when gancyclovir is introduced to the culture (28). 
Targeted ES cells are microinjected into donor mouse blastocysts then transferred 
into the uterine horns of a pseudopregnant recipient female, which is a female that has 
been bred to a vasectomized male so as to prepare the uterus to accept embryos.  
Resultant offspring are called “chimeras” because they are part host embryo-derived and 
part ES cell-derived (28).  If the strains that provided the ES cells and host cells are of 
differing colors, the chimeric coat pattern can be easily identified.  “Typically, chimeras 
are generated from strain 129/Sv (agouti coat color) ES cells and strain C57BL/6 (non-
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agouti, black coat color) host blastocysts (28).”  To test for germline transmission, the 
chimeras are mated to C57BL/6 mice.  If the offspring are agouti, they developed from 
the 129/Sv ES germ cells and the chimeric parent had germline integration.  If they are 
black, the offspring developed from the BL/6 host blastocyst and the chimeric parent 
does not contain the construct in their germ cells (28). 
The selection of mouse strains for use in genetic manipulation is crucial.  In all cases, 
the eggs must be hardy enough to withstand the manipulation procedure itself.  Also, if a 
large number of eggs are required then a donor strain must be selected that responds well 
to superovulation (27).  Lee M. Silver’s book Mouse Genetics, based on strain research 
at NIH, looks closely at these and other characteristics (27). 
The C57BL/6 mouse responds well to superovulation.  3 week-old females can be 
induced to produce anywhere from 40-60 eggs with appropriately timed injections of 
follicle stimulating hormone and human chorionic gonadotropin (27).  It is also the 
“most widely used inbred strain (15).”  It has had its entire genome mapped, making it 
an excellent candidate for transgenic production.  It is also used as a general purpose 
model and as a background strain for “generation of congenics carrying both 
spontaneous and induced mutations (15).”  It was for these reasons that this strain was 
selected as the embryo donor for this project. 
1.3 CRYOPRESERVATION 
 With the wide-spread use of genetic manipulation to create novel strains of mice 
for study, new opportunities emerged for research.  However, with those opportunities 
9 
arose an unforeseen difficulty:  the increased burden on facilities due to the number of 
animals needing to be housed.  The answer to this difficulty was cryopreservation. 
 This technique was first performed successfully in 1972 on mouse embryos.  
Since then, the process has been modified in 1977 to preserve mouse oocytes and in 
1983 to preserve human embryos.  Today, cryopreservation is a common laboratory 
practice, and mouse embryos of all preimplantation stages can be successfully frozen 
(21). 
 Cryopreservation is an important and vital procedure in any laboratory that 
engages in genetic manipulation of embryos for several reasons.  It “reduces 
maintenance costs and safeguards valuable mouse lines against loss (21).”  The cause of 
these losses can be attributed to anything, from infection and disease to breeding failure 
and genetic drift or contamination.  The loss of the research animals can also be 
indicative of husbandry problems, such as flooded cages, inaccessibility to food, or 
similar conditions. 
 This technique is also extremely valuable when rederiving lines following 
infection.  Although conventional or infected strains can be introduced into a specific-
pathogen-free (SPF) colony by hysterectomy of pregnant females just before giving 
birth, there is still a concern that certain viral and bacterial infections can be transmitted 
vertically.  The use of cryopreservation and embryo transfer “has the advantage of 
avoiding postimplantation, vertically transmitted infections (21).”  Cryopreservation and 
embryo transfer have been used together to successfully eliminate mouse hepatitis virus 
(MHV) and Sendai (parainfluenza type 1) virus from colonies (21).    
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 There are a number of factors to consider when utilizing cryopreservation.  
Although all preimplantation stages have been successfully preserved, mouse embryos at 
the eight-cell- and morula-stage are preferred due to their robust nature.  Unlike one- and 
two-cell-stage embryos, they tolerate handling and cryopreservation well.  Upon 
thawing, embryos can be transferred immediately into a pseudopregnant recipient 
female, or they may be cultured in the incubator to determine viability (21).      
1.4 PAIN 
One of the many subjects addressed by McLaren and Michie in their original 
research was the effect of the surgical procedure on the recipient mice (18).  Would the 
trauma caused by the operation render the uterus incapable of nourishing the embryos 
and bringing them to term?  Although their findings suggested that the procedure has no 
adverse effect on the ability of the female to carry the embryos to term, post-operative 
recovery and pain is a concern in any surgical procedure.   
The embryo transfer procedure is classified as major surgery, according to the Guide 
for the Care and Use of Laboratory Animals, because it penetrates and exposes a body 
cavity (22).  An incision is made in the dorsal body wall over the ovarian fat pad and the 
uterine horn is exposed through this incision.  Although the animal is unaware of the 
pain during the surgery, it is likely that there is discomfort during and perhaps even after 
recovery.   
The debate on whether animals feel pain as humans experience it is one that has 
raged for centuries.  One end of the debate can be neatly summarized by Descartes, who 
was quoted as saying, “The greatest of all the prejudices we have retained from our 
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infancy is that of believing that the beasts think (9).”  He believed, as do a great many 
others, that since animals lack the reasoning ability of humans they do not have the 
perception of pain that humans do.  When confronted with avoidance behaviors and 
other reactions in response to stimuli that would cause pain in people, Descartes merely 
responded that these were simply reflexes:  the “response of automatons (9).” 
The other side of the debate is often represented by a quote from Jeremy Bentham, 
an 18
th
 century utilitarian philosopher.  He is quoted as saying, “The question is not can 
they reason?  Nor can they talk?  But can they suffer (9)?”  Suffering is defined by the 
Handbook of Veterinary Pain Management as “the endurance of or submission to 
physical or mental affliction, pain, or loss (10).”  The dog with his abdomen held tense 
and tight; the cat who curls up in one corner of its cage in order to avoid moving; the rat 
who twitches and jumps in its uneasy sleep, waking every few moments to stretch and 
rearrange itself into a possibly more comfortable position; all of these are specific 
examples of animals in discomfort – animals who are submitting to their pain (9). 
Aside from the important ethical reasons, there are also scientific reasons for 
minimizing pain in research animals.  Animals in a stressful situation, such as being 
restrained or put into a new environment, will immediately produce a stress-response in 
their bodies (10).  The physiologic responses to stress, such as increased heart rate and 
breathing rate and the release of epinephrine, actually serve to exacerbate any discomfort 
the animal is feeling.  Such responses may be physically damaging to the animal, and 
may also serve to confound research data (9).       
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In order to properly treat pain, it is important to understand how the body interprets 
and responds to this stimulus.  Physiologists have determined that pain is a protective 
mechanism that serves to warn the body that tissue damage is occurring or is about to 
occur.  The body categorizes pain into three separate groupings, each one represented by 
a different type of nociceptor, or pain receptor.  The three receptors are mechanical, 
thermal, and polymodal.  Mechanical nociceptors respond to pain that results from such 
things as cutting, crushing, or pinching.  Thermal nociceptors respond to extreme 
temperatures, most notably heat.  Polymodal receptors respond equally to many different 
types of damaging stimuli.  Nociceptors, unlike other nerve receptors in the body, are 
simply naked nerve tissue with no specialized receptor structures.  Also unlike other 
nerve receptors in the body, they do not adapt to repeated or sustained stimulation.  They 
do, however, react more strongly whenever prostaglandins are present.  Prostaglandins, 
which are fatty acid derivatives that are released whenever tissue is damaged, lower the 
activation threshold of the nociceptors (10, 26).  
Whenever a painful stimulus is experienced, the impulse travels from the point of 
contact to the central nervous system via one of two different pathways.  Pain signals 
from mechanical or thermal nociceptors travel along small myelinated A-delta fibers at 
incredibly high speeds.  This pathway is termed the fast pain pathway.  It is experienced 
as a sharp, prickling sensation, easily localized.  It is the first type of pain to occur.  The 
second type of pain to occur is stimulated by the polymodal nociceptors.  This message 
travels much slower to the CNS via small unmyelinated C fibers.  This is what produces 
the dull, aching, burning sensation that follows the sharp pain immediately felt upon 
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injury.  This type of pain is harder to pinpoint and lasts much longer than the fast pain 
(10, 26). 
As the pain fibers synapse with second-order interneurons in the dorsal horn of the 
spinal cord, two different neurotransmitters are released.  Substance P activates 
ascending pathways that relay the pain signal to higher levels for further processing.  
These pathways eventually end in the somatosensory cortex, the thalamus, and the 
reticular formation.  It is this part of the pain pathway that is unclear.  It is thought, 
however, that the reticular formation increases the alertness associated with the painful 
encounter.  Connections between this and the hypothalamus and limbic system elicit the 
emotional and behavioral responses that accompany the painful experience (10, 26). 
Glutamate, the second neurotransmitter released by the afferent pain fibers, is a 
major excitatory neurotransmitter.  Glutamate binding to two different plasma-
membrane receptors on the dorsal horn neurons serves two different purposes.  First, 
when it binds to AMPA receptors it generates an action potential in the dorsal horn cell.  
These action potentials serve to carry the pain message to higher nerve centers.  
Secondly, when it binds to NMDA receptors it allows calcium ions to enter the dorsal 
horn cell, which makes the neuron more excitable than usual.  This results in the 
exaggerated hypersensitivity of an injured area (10, 26).   
1.5 ANALGESICS 
There are four classes of analgesic drugs:  opioids, nonsteroidal anti-inflammatory 
drugs (NSAIDs), alpha-2 agonists, and local anesthetics (10).  This paper will focus on 
the opioids and the NSAIDs, as the drugs used in this study belong to those two classes. 
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As defined by the Handbook of Veterinary Pain Management, opioids are “any one 
of a growing number of natural or synthetic compounds that produce morphine-like 
effects by acting on opioid receptors (10),” the desired effect being analgesia.  Opioid 
receptors can be found on the endings of afferent pain fibers that release Substance P.  
Opioids act by blocking the release of Substance P and thereby blocking the pain signal 
from entering the higher levels (10).   
Opioids are classified into three groups:  1) antagonists, 2) agonists, and 3) agonist-
antagonists and partial agonists.  Opioid antagonists do not produce analgesia and are 
used to either block or reverse the effects of opioid agonists.  Opioid agonists work at the 
opioid receptors by binding and producing the analgesic effects.  Agonist-antagonists 
and partial-agonists produce the analgesic effects of the agonists but not as strongly and 
are generally less toxic.  Studies have shown them useful for helping heroin addicts 
overcome withdrawal symptoms (9). 
Opioid receptors have three different subtypes, and each opioid shows a certain 
affinity and action for each of the subtypes.  Mu receptors are responsible for 
supraspinal, spinal, and peripheral analgesia.  Opioids that act at this receptor give a 
minimal to mild sedation.  Kappa receptors are responsible for supraspinal and 
peripheral analgesia and possibly spinal analgesia as well.  Drugs that work at this 
receptor give minimal sedation.  Delta receptors give supraspinal, spinal, and peripheral 
analgesia and minimal sedation.  A fourth receptor, sigma, was once included but is now 
recognized as not fitting the required criteria (9, 10).   
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Nonsteroidal Anti-inflammatory Drugs, commonly known as NSAIDs, are perhaps 
the most popular class of analgesics in use in small animal veterinary medicine, 
according to the Handbook of Veterinary Pain Management.  NSAIDs produce analgesia 
by inhibiting arachidonate cyclooxygenase synthase (COX), which in turn produces 
prostaglandins.  Prostaglandins lower the activation threshold of nociceptors which 
makes them more responsive to less stimuli (9, 10). 
There are two different types of COX.  COX-1 is responsible for maintaining tissue 
homeostasis and is involved in cell signaling.  COX-2 is induced in inflammatory cells 
and is responsible for the production of inflammatory mediators.  The inhibition of 
COX-1 is thought to be responsible for the acute and chronic toxicities produced by 
some NSAIDs.  Most NSAIDs available today inhibit both isoforms of COX, so it is 
important to be aware of proper dosages (9, 10).  
For this project, one drug from each of these two categories, buprenorphine and 
ketoprofen, was selected on the basis of Paul Flecknell’s research into rodents and pain.  
Buprenorphine is a very potent opioid partial-agonist at the mu receptors.  It has an 
extremely high affinity for these receptors, although it is very slow to bind with them.  
This is reflected in the slow onset of action displayed by this drug, which can be 
anywhere from 30 minutes to an hour.  Buprenorphine tends to stay in the body for long 
periods of time, with a half-life in dogs of around 42 hours.  However, it does not have a 
long duration of action in the dog, which can last anywhere from 4 to 8 hours.  There 
have not been many clinical trials of the use of buprenorphine or other opioids in small 
rodents.  Buprenorphine has the longest duration of action of the opioids, which makes it 
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a clear choice for use in small rodents, as their small body size and fast metabolism 
enables them to clear drugs from their system much faster than a dog.  The best time to 
dose a rodent remains unknown, however.  The long onset of action leads some to 
believe that it is best to dose pre-operatively, while some studies undertaken show that a 
single dose of buprenorphine either intraoperatively or post-operatively does well for 
controlling surgical pain.  One thing to remember when using this drug, however, is that 
at higher or more frequent dosages the antagonist action takes over, actually rendering 
the drug useless at providing analgesia.  Smaller dosages appear to work best at 
providing analgesia (9).       
Ketoprofen is licensed for use in a wide variety of animals, such as the dog, cat, 
horse, and cow.  It is a very potent non-selective inhibitor of COX and displays both 
analgesic and anti-inflammatory properties.  Post-operative use in dogs and cats to 
provide pain relief has been reported to be very effective, although there is concern with 
toxicity when given over prolonged periods.  As with the opioids, there is little clinical 
experience in giving ketoprofen to small rodents.  However, its use is becoming more 
widespread and no evidence of adverse reactions has yet been reported.  It is advisable to 
dose post-operatively to give the greatest benefit of analgesia possible; some reports 
have stated that a single dose can provide up to 24 hours of relief (9). 
Many researchers are reluctant to use analgesics in their animals for multiple 
reasons.  Analgesics may not have been used when collecting previous data, thereby 
calling into question the comparative validity of results.  Some investigators do not wish 
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to add another variable to their work, especially since few studies have been done on the 
effects analgesics may have. 
For this study, three surgical groups of mice were used to determine the effects of 
analgesics on embryo transfer procedures.  For each experiment, a set number of 
embryos was injected into each of three mice, which were dosed either with ketoprofen, 
buprenorphine, or saline as a control.  Mice were evaluated post-operatively for pain 
behaviors.  Each mouse was observed and the number of pups born and the number of 
pups that survived until weaning was recorded and measured against the number of 
embryos injected.   
This research project was undertaken to provide investigators more data regarding 
the effects of analgesic administration on reproductive efficiency in mice.  The increased 
use of analgesics is heavily encouraged, yet there is little information detailing the 
effects the administration of such drugs may have.  This is of critical import in embryo 
transfer, especially considering the number of laboratories using this procedure across 
the country.  Embryo transfer has a wide range of applications, from rederivation of a 
genetic line after a disease outbreak, reinstating a line following cryopreservation, to 
production of an entirely new transgenic or knock-out animal for study.  Efficiency of 
transfer in such a situation is very important, especially when taking into account the 
number of embryos that must be manipulated and transferred to ensure founders are 
produced.  Two separate types of analgesics were studied to compare the effects on 
reproductive efficiency. 
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2.  MATERIALS AND METHODS 
2.1 ANIMALS 
The procedures enumerated here were done with the approval of the Texas A&M 
University Laboratory Animal Care Committee, following Institutional Animal Care and 
Use guidelines.  Female and male C57BL/6 mice from NCI, female Swiss Webster mice 
from Harlan and vasectomized Swiss Webster and ICR male mice from Harlan were 
selected for this project.  All animals were housed at Texas A&M University’s 
Laboratory Animal Resources and Research (LARR) facility, which is accredited by the 
Association for the Assessment and Accreditation of Laboratory Animal Care 
(AAALAC), International.  All animals were housed and cared for according to the 
Guide for the Care and Use of Laboratory animals.  Females were housed five to a cage 
and separated by strain, whereas the males were singly-housed.  All were housed in 
standard clear polycarbonate rodent cages (standard polycarbonate mouse cage, 
17”x8.5”x6”; Allentown Caging Co., Allentown, NJ) with pine bedding (PWI Brand; 
PRO-CHIP 8/16, Aspen Hardwood Sawdust; P.W.I. Industries, Inc.) and kept on a 
12L:12D light cycle (lights on at 0700 and off at 1900).  After 18 experimental groups 
had undergone treatment, the light cycle was changed to a 14L:10D (lights on at 0600 
and off at 2000) for the remaining 35 groups.  Humidity was kept at around 60% and the 
temperature held at a constant 70
o
F, +/- 3 degrees.  Animals had free access to a 4% 
standard laboratory chow (Harlan Teklad Laboratory Diets; Teklad Rodent Diet (W); 
8604).  After 18 experimental groups had undergone treatment, the females in the study 
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were changed to a 9% fat diet (Lab Diet:  Mouse Diet 9F #5020).  Tap water was 
available ad libitum. 
2.2 SUPEROVULATION   
C57BL/6 embryo donor females were injected intraperitonealy (i.p.) with 0.1 ml 
(5 I.U.) of PMSG (gonadotropin; Pregnant Mare Serum; G-4877; Sigma-Aldrich Co) 
followed 48 hours later with an i.p. injection of 0.1 ml (5 I.U.) hCG (chorionic 
gonadotropin; CG-5; Sigma-Aldrich Co).  Upon arrival, PMSG was diluted to 200 I.U. 
(1ml) aliquots and hCG diluted to 500 I.U. (1ml) aliquots.  Three mls of saline was 
added to the PMSG so that 4ml equaled 200 I.U.  Once this solution had been 
thoroughly mixed, 0.1ml (5 I.U.) was drawn up into tuberculin syringes and frozen at 
4
0
C until needed.  To the hCG was added 9ml of saline so that 10ml equaled 500 I.U.  
After agitating the solution to ensure even distribution of the hormone in the saline, 
0.1ml (5 I.U.) were drawn up into tuberculin syringes and frozen at 4
0
C until needed.  
Following hCG administration, mice were immediately placed with intact males of the 
same strain and checked the following morning for copulatory plugs.  Plugged females 
were considered to be at 0.5 day pregnancy.  Plugging success for the males was 
recorded on their cage cards.  All females were returned to their home cages regardless 
of whether they plugged or not.  Recipient females were placed with vasectomized males 
in a 1:2 breeding, two females placed in a single male’s cage, that same afternoon.  Mice 
were checked the following morning for copulatory plugs, which was recorded as 0.5 
day pseudo-pregnancy.  Plugging success for the males was recorded on their cage card.  
Plugged females were placed in a separate cage while unplugged females were returned 
20 
to their home cages.  Two unplugged females were selected as non-surgical controls.  
For a uterine transfer, surgery was scheduled so the embryos would be 3.5 days at 
collection and the recipients would be 2.5 days post-coitus.  For an oviduct transfer, 
surgery was scheduled so that the embryos would be 2.5 days at collection and the 
recipients would be 0.5 days post-coitus. 
2.3 EMBRYO COLLECTION 
The evening before a uterine transfer surgery, a four-well plate was prepared 
with M16 solution (M7292; embryo tested; Sigma-Aldrich Co) and mineral oil (M8410-
500ML; embryo culture tested; Sigma-Aldrich Co) and placed in a water-jacketed CO2 
incubator (Nuair US Autoflow CO2 Water-Jacketed Incubator, Model NU-4750; 37
o
C, 
5.7% CO2).  On the morning of surgery, M2 solution (M7167; embryo tested; Sigma-
Aldrich Co.) was removed from the refrigerator and placed in a petri dish one half hour 
before collection to warm it to room temperature.  Donor females were sacrificed via 
cervical dislocation around 0700.  The entire uterus was removed and placed in a small 
petri dish of M2 solution.  Removal of the uterus from the five females took 
approximately 10 minutes.  The uterus was flushed with a 3ml syringe filled with the 
room-temperature M2 solution and a 27G or 30G needle.  Each uterus was flushed into 
its own petri dish so that embryo yield per animal could be recorded.  Flushing took 
approximately 10-15 minutes.  After flushing, embryos were counted and graded to 
determine which would be transferred. 
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The grading system was a scale from 1 to 4.  Embryos of “excellent” or “good” 
quality were enumerated as 1 (Figure 1).  These embryos had an inner cell mass as well 
as a proliferative trophectoderm layer of cells.  “Fair” embryos were called 2 and also 
had an inner cell mass.  Most of the trophectoderm layer of cells were actively 
reproducing.  Characteristics of a grade 3 or “poor” embryo were a barely visible inner 
cell mass as well as less than half of the trophectoderm layer of cells actively 
proliferating.  Vacuoles were present nearly all of the time.  “Dead or degenerating” 
embryos were called 4 and displayed no inner cell mass, and had no proliferation of the 
trophectoderm layer of cells as well as a completely vacuolated cavity.  These embryos 
were also frequently dark when viewed as compared to embryos of other grades, a visual 
signal that they were dead or dying (Figure 2).  Only embryos of 1 or 2 quality were 
used in surgical procedures.  Embryos of 3 or 4 quality were placed back into the 
incubator to be used for non-survival surgical practice.       
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Figure 1.  Embryos, Grade 1 and 2.  Embryo (A) is of grade 2 due to the presence of 
foreign bodies (indicated with arrow).  Embryos (B) and (D) are of grade 1 and are 
expanded blastocysts.  Embryo (C) is actively expanding.  The arrow indicates the 
proliferating trophectoderm layer and the last remaining vestige of the inner cell mass. 
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Figure 2.  Embryos, Grade 3 and 4.  The arrows indicate unfertilized ova.  The rest of 
the embryos are either degenerating or dead, and cannot be used for transfer.  
 
The procedure differed only slightly for an oviduct transfer.  Females were 
superovulated and mated according to the same protocol mentioned before.  The 
embryos were collected at 2.5 days post coitus, while at the 8-cell stage.  Females were 
sacrificed via cervical dislocation and opened to harvest the oviducts and part of the 
uterine horns.  The embryos were flushed into a dish with M2 solution by inserting a 
filled 1cc syringe with a dulled 30G needle into the infundibulum.  
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2.4 CRYOPRESERVATION OF EMBRYOS 
The Biocool unit was turned on to allow it to reach proper temperature at -6
0
C, 
and the prepared glycerol cryoprotectant (10.96 ml glycerol (embryo tested, G-2025 
SIGMA) per 100ml final volume M2) and the sucrose solution (1.71 gm sucrose 
(embryo tested, S-1888 SIGMA) per 50ml final volume M2) were removed from the 
refrigerator, and put on ice.  These solutions were filter sterilized and aliquoted into a 
sterile petri dish.  Media dishes with M2 solution were set up to hold the embryos until 
ready to be frozen.  Straws were labeled according to cryopreservation protocol:  Straw 
number in the top left-hand corner, date frozen in the top right-hand corner, the line 
being frozen in the middle, and number of embryos in the straw in the bottom left-hand 
corner, along with the initials of the person performing the preservation.  This 
information was also recorded in the freezing log book.  A cotton plug was pushed down 
into the straw, and the measurements were marked (1cm, 7cm) on the straws with a cryo 
pen.  Using a Monoject 1cc syringe, the sucrose solution was sucked up to the 7cm 
mark, followed by a column of air, then the glycerol solution to the 1cm mark, then a 
final column of air.  Around 20-60 embryos were transferred into each straw in the 
glycerol section of the straw using a mouth pipet, followed by an air bubble and a small 
amount of sucrose.  Both ends of the straw were heat sealed.  Straws ready to be frozen 
were placed into the Biocool at -6
0
C and left for 5 minutes.  Afterward, straws were 
seeded using forceps dipped in liquid nitrogen.  Once all straws were seeded, the 
freezing program was run on the Biocool.  After the program was completed at an 
25 
ending temperature of approximately -46
0
C, the straws were placed in liquid nitrogen for 
storage. 
2.5 THAWING PROCEDURE FOR CRYOPRESERVED EMBRYOS 
The straw was first removed from the liquid nitrogen tank and balanced 
horizontally between two racks for three minutes, making sure that the embryo column 
was not touching any surface.  If present, condensation was wiped off with a Kim wipe 
before proceeding.  The straw was held by the cotton tip and shaken like a thermometer 
until the air bubble rose to the top of the straw.  It was then placed in the incubator at 
37
0
C in a water-filled beaker for three minutes.  The straw was removed from the 
incubator and placed upside down in a second beaker filled with room-temperature water 
for three minutes.  The end opposite the cotton plug was cut, then a cut made through the 
center of the cotton plug.  A metal rod was used to push all the fluid from the straw into 
a petri dish, taking care that the cotton plug did not come out or touch the bubble of 
fluid.  The embryos were then washed through several drops of M2 media and either 
cultured for later use or transferred to a recipient female immediately. 
2.6 CULTURING PROCEDURE 
To culture the embryos, M16 media was covered in embryo tested mineral oil 
and placed in a CO2 water-jacketed incubator (5.7% CO2, 37
0
C).  It was left in the 
incubator for several hours, usually overnight, to allow it to equilibrate before the 
embryos were placed in the media.  2.5 day embryos, anywhere from two- to eight-cells, 
were either used immediately in an oviduct transfer, or allowed to culture until they 
developed into blastocysts, usually after 24 hours.  Embryos collected at 3.5 days, at 
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blastocyst stage, were used immediately in uterine transfers.  Embryos collected at 0.5 
days, at 1-cell stage, were mixed with hyaluronidase (2900 μL M2 plus 100 μL 
hyaluronidase) (10mg/ml) approx 2 minutes to remove cumulus cells, washed in M2 and 
then cultured to later stage embryos. 
2.7 SURGICAL PROCEDURE 
The recipient and control females were weighed and analgesic and anesthetic 
doses calculated.  The anesthetic, a ketamine/xylazine cocktail, was given at 10mg/kg.  
The cocktail was mixed at 70mg/kg : 7mg/kg ketamine to xylazine.  The ketoprofen 
analgesic was dosed at 10mg/kg and was mixed as 1mg/ml (0.1ml ketoprofen at 
100mg/ml plus 9.9ml sterile water).  Buprenorphine was dosed at 1mg/kg and was 
mixed as 1ml (0.3mg) buprenorphine plus 4ml sterile water.  One hour prior to surgery, 
the buprenorphine (surgical and non) and saline mice were injected with appropriate 
doses of their respective analgesic.  Ketoprofen mice were injected with their analgesic 
mixed with 2ml of warmed saline post-surgically.  All mice were anesthetized with a 
ketamine/xylazine cocktail injected i.p.  Mice were placed in a warmed standard mouse 
cage for five minutes post-injection to ensure they were asleep.  Depth of anesthesia was 
determined by pinching toes and tail with a pair of forceps.  The tail was tested first, and 
if no tail flick reaction occurred a toe on a hind paw was pinched.  If a withdrawal reflex 
occurred, the depth of anesthesia was inadequate.  Once appropriate anesthesia depth 
had been reached, the dorsal surgical area – from the last rib to 1 cm cranial to the base 
of the tail - was shaved and scrubbed with a 10% betadine solution and 70% isopropyl 
alcohol, and an artificial tear solution (Artificial Tears Ointment, Lubricant Eye 
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Ointment (sterile), Phoenix Pharmaceutical, Inc.) was placed on the eyes.  To prevent 
anesthetic hypothermia, since an anesthetized mouse cannot regulate its body 
temperature, the animal was placed in a plastic petri dish lid set on top of a covered 
warmed slide warmer.  Time was recorded at first incision.   
In the uterine transfer procedure, a horizontal incision approximately 1 cm in 
length was made on the dorsal surface of an anesthetized, recumbent mouse.  Blunt 
dissection was used to separate the skin from the fascia underneath.  The incision was 
then positioned over the left ovarian fat pat, which can be seen through the transparent 
body wall.  A small incision was then made to enter the body wall and the ovarian fat 
pad was exteriorized.  A sterile bulldog clip was used to anchor the fat pad on the 
dorsum.  The mouse was then placed under a dissecting microscope.  A hole was pierced 
into the uterine wall with a 27G needle and the tip of a pulled glass pipette loaded with 
embryos was threaded through the hole into the uterus.  Five or six embryos were blown 
into the uterine horn, along with a small amount of M16 solution.  The pipette was 
checked to be sure all embryos had been transferred.  The exposed uterine horn was 
moistened with a small amount of warmed saline and then returned to the body cavity.  
The body wall incision was closed with a single suture of 5-0 silk (Oasis; 5-0 Silk-oasis 
nonabsorbable suture; MV-682).  The entire procedure was repeated for the right side 
with 10 or 12 embryos total per mouse being transferred.   
In an oviduct transfer, an incision was made through the body wall avoiding 
nerves and large blood vessels.  The incision was manipulated until the white fat pad 
surrounding the ovaries was visible.  Dull forceps were used to grasp the fat pad and 
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gently pull it out through the incision.  Using a microscope, the ovary was positioned for 
easy access to the oviduct then clamped outside the body with a small, sterile bulldog 
clip on the fat pad.  Twelve embryos at 2.5 days (two- to eight-cell stage) were pipetted 
into a small drop of warmed M2 solution.  A transfer pipette, with a tip diameter slightly 
larger than the embryos, was loaded with M2, followed by a 2-5 mm air bubble, and then 
the media with the 12 embryos for transfer.  The pipette was then carefully set aside until 
it was time to use it.  At this point, the mouse was moved back under the microscope.  
The bursa surrounding the oviduct was gently torn open with two pairs of forceps, giving 
the surgeon access to the infundibulum, the funnel-like dilation at the distal end of the 
uterine tube that provides a path from the ovary to the uterine horn.  Tearing the bursa 
sometimes caused a small amount of bleeding, which was gently blotted up using a 
sterile cotton swab.  The tip of the pipette loaded with 12 embryos was slid into the 
infundibulum and the contents gently expelled until the air bubble was visible within the 
oviduct.  The pipette tip was carefully removed and checked beneath the microscope to 
ensure the embryos were transferred.   The ovarian fat pad and uterus were gently 
replaced into the abdominal cavity, and the body wall closed with one or two interrupted 
sutures of 5-0 silk.  Oviduct transfers were done on one side of the body only, while 
uterine transfers were done on both sides of the body.  Embryos transferred into the 
infundibulum of the oviduct will migrate across both horns and distribute evenly in the 
uterus.  Transferring an equal number of embryos into both horns, therefore, helps 
prevent dystocia due to a lack of equilibrium between the uterine horns. 
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In both procedures, the skin incision was closed with a sterile steel surgical clip 
and the surgical site scrubbed with hydrogen peroxide (Swan solution of Hydrogen 
Peroxide; 3% H2O2 U.S.P.) to clean it.  The mouse was given 2ml of warmed saline – 
1ml subcutaneously and 1ml i.p. – then placed on a water circulating heating pad.  Mice 
in the ketoprofen group, surgical and non, were given their dose of ketoprofen mixed 
with the warmed saline.  Each mouse was observed during the recovery period and times 
were recorded for first movement and walking.  Upon demonstrating reliable movement, 
the mouse was returned to the warmed cage.  Mice were identified via conventional ear 
marks in the right ear numbering 1 through 5.  
2.8 OBSERVATIONS 
Mice were left in the warmed cage for 4-5 hours before being placed in 
individual cages for observation.  It was unknown to the observer which mouse was in 
which cage.  Two observation periods of 5 minutes each were used, one at 1800 and one 
at 1830 hours.  The mice were scored on three different parameters:  Physical Condition, 
Behavior, and Posture (Table 1). 
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Physical Condition focused on observations on Hair Coat and Eyes and Nose, 
with a score from 0 (normal) to 2 (abnormal) being assigned.  Behavior focused on 
Activity and Temperament, with 0 being normal and 3 being agitated and aggressive.  
Posture focused on Stance and Locomotion, with 0 being normal and 3 being prone and 
motionless. 
Scores given were determined by the observer’s subjective criteria, based on her 
observations of “normal” mice and of the surgical mice during recovery.  Mice received 
a score of 1 in Hair Coat if they were not actively grooming during the observation, as 
this rating was confounded by the surgical preparation.  For Behavior, if the mouse was 
not moving except for slight twitching it received a score of 1 in Activity.  If it was 
moving around the cage, but at a fast pace punctuated by frantic digging or climbing the 
cage walls, the Activity was recorded as 0 but Temperament was recorded as a 1 or 2.  
For Locomotion, if the mouse was moving on its own it was recorded as 0.  Movement 
following a single tap on the cage was recorded as 1.  Several taps was recorded as 2, 
and if the cage had to be opened to produce movement it was recorded as 3. 
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Table 1.  Behavior Scores.  Scoring criteria adapted from Gillingham, et.al. (11) 
Physical Condition 
Score Hair Coat Eyes and Nose 
0 Normal, well-groomed Normal, no discharge 
   
1 Rough, dirty, 
ungroomed 
Eyes closed or squinted, 
no discharge 
   
2 Rough, hair loss, 
ungroomed 
Eyes closed or squinted, 
discharge 
  
Behavior 
Score Activity Temperament 
0 Normal Normal – not agitated 
   
1 Not moving around Mildly agitated 
   
2 Agitated – chewing on 
cage 
Moderately agitated 
   
3 Very agitated, chews 
on feet/tail 
Severe agitation, 
aggressive 
  
Posture 
Score Stance Locomotion 
0 Sitting in normal 
resting position 
Voluntary locomotion 
   
1 Sitting in hunched 
position 
Slight stimulation needed 
   
2 Hunched posture/head 
on floor 
Moderate stimulation 
needed 
   
3 Lying prone on floor No locomotion after 
moderate stimulation 
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After the second observation, it was determined which mouse had received what 
treatment and scores were totaled for each period.  The three surgical mice were housed 
together and the two non-surgical controls were euthanized.  The three surgical females 
were observed daily for signs of pregnancy and separated into individual cages 5 days 
before their due date which was 18 days post-op.  Females who did not appear pregnant 
during these 18 days were sacrificed on their due date and their uteri examined for signs 
of resorbed embryos.  Females who did appear pregnant but did not give birth by 2 days 
past their due date were sacrificed and their uteri checked for signs of pregnancy.  The 
date and number of pups born were recorded.  The pups were checked daily and any 
change in numbers was recorded.  Pups were weaned at 21 days and set aside for later 
use in the project.    
2.9 STATISTICAL ANALYSES 
 An analysis of covariance (ANCOVA) was selected as the method to test our 
hypotheses.  To test all of our null hypotheses that the means of one treatment group 
matched the means of another treatment group using the Students’ t test would result in a 
grossly unacceptable Type I error, due to the fact that several tests would have to be run.  
In an analysis of variance (ANOVA), means of the variables of interest are compared by 
splitting the overall observed variance into different parts.  This allows several 
hypotheses to be tested at once without increasing the probability of a Type I error.  The 
statistical model of an ANCOVA follows the same model as an ANOVA, allowing 
multiple hypotheses to be tested at the same time without increasing the probability of 
Type I error.   
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 Although our recipient females were identical in terms of strain and housing and 
were age-matched as closely as possible, their weights varied from under 20 grams to 
nearly 40 grams (Figure 3).  In order to control for any effect this weight difference may 
have on our dependent variables, weight of the animal was set as a covariate.  A 
covariate is defined as a variable that is possibly predictive of the dependent variables 
under study.  Covariates can either be a confounder or an effect modifier. 
 
   
 
Figure 3.  Weights of all Recipient Females.  Histogram showing the distribution of 
weights for the recipient females.  All three treatment groups (saline, ketoprofen, 
buprenorphine) and both surgical groups (uterine and oviduct) are represented. 
 
 The hypotheses tested using the ANCOVA method of analysis were the effects 
of the perioperative administration of ketoprofen or buprenorphine on the number of 
pups born and surviving to weaning age when compared with a saline control.  Analyses 
were run for the two different types of embryo transfer procedures:  uterine and oviduct.   
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 An ANOVA was used to determine whether the administration of the analgesics 
had any effect on post-operative behavior when compared with a surgical saline control 
and a non-surgical analgesic control.  Total scores for the first and the second 
observational periods were used, as well as total scores for the three major behavior 
categories.   
 Pearson’s chi-squared test was used to analyze the relationship between the 
independent variables and a dichotomous outcome; namely, whether a recipient female 
had a litter or not.  Chi-squared tests determine if the relative frequencies of the 
occurrence of observed events follow a frequency distribution; in other words, it tests for 
associations between factors.  This allowed us to examine the extent to which exposure 
to one of our independent variables determined whether our females gave birth to a litter.  
Tests were run with the independent variables as given no dose or dose, where saline 
was compared with ketoprofen in one analysis and then with buprenorphine in a second 
analysis.  In each case, the response variable of no litter/litter was examined.   
 The statistical program Stata was used to run our ANOVA/ANCOVA and chi-
squared models. 
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3.  RESULTS 
3.1 UTERINE TRANSFERS 
 38 experimental groups underwent the uterine transfer procedure, each group 
consisting of three surgical mice and two non-surgical controls.  The effects of 
administering ketoprofen, buprenorphine, and a saline control were evaluated in regards 
to number of pups born, number of pups weaned, as well as whether a litter was 
delivered or not.  The number of pups born was a total count of all pups living or dead.  
The number of pups weaned chronicled only the animals that survived to weaning age 
(21 days).  The weight of the recipient animal was taken into consideration as a covariate 
in an analysis of variance (ANOVA). 
 The number of litters born in the saline and ketoprofen groups is summarized in 
Table 2.  Table 3 looks at the number of litters born in the saline and buprenorphine 
groups.  Figure 4 depicts graphically the number of pups born and weaned in each of the 
treatment groups.  Figure 5 shows the average number of pups born and weaned and the 
standard deviations across the three treatment groups. 
 
Table 2.  Number of Litters Born by Saline and Ketoprofen Groups, Uterine 
Surgery Only. 
UTERINE Treatment Group 
Litter 
Born 
Saline Ketoprofen 
Yes 14 15 
   
No 23 23 
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Table 3.  Number of Litters Born by Saline and Buprenorphine Groups, Uterine 
Surgery Only. 
UTERINE Treatment Group 
Litter 
Born 
Saline Buprenorphine 
Yes 14 17 
   
No 23 20 
 
 
 
 
 
Figure 4.  Number of Pups Born by Treatment Groups, Uterine Surgery Only.  The 
median value in all three groups was 0.  The average number of pups born to the saline 
group was 1.54, for ketoprofen the average was 1.60, and the average number for 
buprenorphine was 1.51. 
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Figure 5.  Summary of Pups Born and Weaned by Treatment Groups, Uterine 
Surgery Only.  Figure 5A shows the average number of pups born across the three 
surgical treatment groups and the standard deviation for each group.  There is no 
significant difference across the three groups at the 0.05 significance level.  Figure 5B 
shows the average number of pups weaned across the three surgical treatment groups 
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(Figure 5, Continued) and the standard deviation for each group.  Again, no significant 
difference is seen in the three groups at the 0.05 significance level. 
 
 An ANOVA table was used to determine any significant differences in number 
of pups born in the three treatment groups, using weight of the recipient animal as a 
covariate.  The results from this analysis indicate that the number of pups born is not 
affected by the pre-operative administration of buprenorphine or post-operative 
administration of ketoprofen when compared with the administration of a saline control 
(P=0.9810). 
 The same analysis was used to determine any significant differences in number 
of pups weaned in the three treatment groups, once again using the recipient weight at a 
covariate.  Once again, the results indicate that the administration of buprenorphine or 
ketoprofen, when compared with the administration of a saline control, has no effect on 
the number of pups surviving until weaning age (ANCOVA, P=0.9526). 
 Pearson’s chi-square was used to determine any differences in numbers of litters 
born across the three treatment groups.  Litters born was set as a “yes/no” response 
variable that did not take into account number of pups born or number of pups surviving 
until weaning.  Two chi-squared tests were run, one that compared the saline treatment 
group to the ketoprofen group, and a second analysis comparing the saline treatment 
group to the buprenorphine treatment group.  In this fashion, the outcome was evaluated 
on a “no dose/dose” basis.  Analysis showed that there was no difference between the 
“no dose” treatment (saline) and the “dose” treatment (ketoprofen or buprenorphine) in 
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regards to whether a litter was born or not (P=0.884 with chi
2
=0.02 for saline and 
ketoprofen, and P=0.4794 with chi
2
=0.50 for saline and buprenorphine).   
3.2 OVIDUCT TRANSFERS 
15 experimental groups underwent the oviduct transfer procedure, each group 
consisting of three surgical mice and two non-surgical controls.  The effects of 
administering ketoprofen, buprenorphine, and a saline control were evaluated in regards 
to number of pups born, number of pups weaned, as well as whether a litter was 
delivered or not.  The number of pups born is a total count of all pups living or dead.  
The number of pups weaned chronicles only the animals that survived to weaning age 
(21 days).  The weight of the recipient animal was taken into consideration as a covariate 
in an analysis of variance (ANOVA). 
 The number of litters born in the saline and ketoprofen groups is summarized in 
Table 4.  Table 5 summarizes the number of litters born in the saline and buprenorphine 
group.  Figure 6 depicts graphically the number of pups born and weaned in each of the 
treatment groups.  Figure 7 shows the average number of pups born and weaned and the 
standard deviations across the three treatment groups. 
 
Table 4.  Number of Litters Born by Saline and Ketoprofen Groups, Oviduct 
Surgery Only. 
OVIDUCT Treatment Group 
Litter 
Born 
Saline Ketoprofen 
Yes 8 7 
   
No 3 3 
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Table 5.  Number of Litters Born by Saline and Buprenorphine Groups, Oviduct 
Surgery Only. 
OVIDUCT Treatment Group 
Litter 
Born 
Saline Buprenorphine 
Yes 8 7 
   
No 3 4 
 
 
 
 
 
Figure 6.  Number of Pups Born by Treatment Groups, Oviduct Surgery Only.  The 
average number of pups born in the saline group was 1.55, for ketoprofen the average 
was 1.9, and the average number for buprenorphine was 2. 
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Figure 7.  Summary of Pups Born and Weaned by Treatment Groups, Oviduct 
Surgery Only.  Figure 7A shows the average number of pups born across the three 
surgical treatment groups and the standard deviation for each group.  There is no 
significant difference across the three groups at the 0.05 significance level.  Figure 7B 
shows the average number of pups weaned across the three surgical treatment groups 
and the standard deviation for each group.  Again, no significant difference is seen in the 
three groups at the 0.05 significance level. 
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An ANOVA table was used to determine any significant differences in number 
of pups born in the three treatment groups, using weight of the recipient animal as a 
covariate. The results from this analysis indicate that the number of pups born is not 
affected by the pre-operative administration of buprenorphine or post-operative 
administration of ketoprofen when compared with the administration of a saline control 
(P=0.6876). 
 The same analysis was used to determine any significant differences in number 
of pups weaned in the three treatment groups, once again using the recipient weight at a 
covariate.  Once again, the results indicate that the administration of buprenorphine or 
ketoprofen, when compared with the administration of a saline control, has no effect on 
the number of pups surviving until weaning age (ANOVA, P=0.6697). 
 Pearson’s chi-square was used to determine any differences in numbers of litters 
born across the three treatment groups.  Litters born was set as a “yes/no” response 
variable that did not take into account number of pups born or number of pups surviving 
until weaning.  Two chi-squared tests were run, one that compared the saline treatment 
group to the ketoprofen group, and a second analysis comparing the saline treatment 
group to the buprenorphine treatment group.  In this fashion, the outcome was evaluated 
on a “no dose/dose” basis.  Analysis showed that there was no difference between the 
“no dose” treatment (saline) and the “dose” treatment (ketoprofen or buprenorphine) in 
regards to whether a litter was born or not (P=0.890 with a chi
2
=0.02 for saline and 
ketoprofen, and P=0.648 with a chi
2
=0.21 for saline and buprenorphine). 
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 Several possible correlations beyond the original intent of this project were also 
tested.  It was theorized at one point that the weight of the recipient animal may have an 
effect on whether she is able to carry the embryos to term and perhaps even how many 
she can carry to term.  However, no correlation between weight and whether or not an 
animal had pups (P=0.1399), or between weight and number born (P=0.2332) was 
found. 
 This project utilized both fresh and frozen embryos, realizing that researchers 
engaging in embryo transfer operations would be using both types.  For our purposes, 
“fresh” embryos included both those collected on the day of surgery and transferred 
immediately, as well as embryos collected a day early and allowed to incubate overnight.  
Possible correlations between embryo type (fresh or frozen) and whether or not a litter 
was born, as well as the number of pups born, were explored.  Results showed that the 
type of embryo did not have any effect on litters born (P=0.9260) or number of pups 
born (P=0.2466).  
3.3 BEHAVIOR 
 53 groups of mice, for a total of 265 individual animals, were studied over the 
course of this experiment.  Mice were scored as individuals in their surgical groups and 
the results tabulated.  Scores for each behavior category were compared between the 
surgical treatment groups (Saline, Ketoprofen, Buprenorphine), and the surgical versus 
nonsurgical control counterpart (Ketoprofen and Buprenorphine).  
 Although the behaviors enumerated in the scoring system were known as well-
established indicators of discomfort in mice, the severity of discomfort based on those 
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behaviors is very subjective and controversial.  Because of this subjectivity, the 
difference between a behavior score of 1 and 2 was not equal to the difference between 2 
and 3.   
 To remedy this, behavior scores were simplified to a “normal” and “abnormal” 
response.  The behavior criteria mentioned before were still used as a guideline, but now 
any abnormal behavior was recorded as a response regardless of severity.   
 For statistical purposes, the scores were further combined.  A total score was 
taken for each observation period across the six individual behavior subcategories (hair 
coat, eyes and nose, activity, temperament, stance, and locomotion).  In addition, the six 
subcategories were collapsed into three major categories:  Physical condition consisted 
of hair coat and eyes and nose; behavior was activity and temperament combined; and 
posture took into account stance and locomotion.  These scores were independent from 
and not included within the total scores for the observational periods. 
 Using an ANOVA table, the total behavior scores for periods one and two were 
analyzed by treatment groups, looking only at the mice that underwent surgery.  Results 
indicated that the use of ketoprofen or buprenorphine had no effect on post-operative 
behavior when compared to a saline control (P=0.8422 for period 1 and P=0.8307 for 
period 2).  Next, total behavior scores for the two periods were compared between the 
surgical mice who received ketoprofen and their non-surgical counterpart.  Results 
indicated that surgery had no effect on the behavior of the mice who received ketoprofen  
(P=0.8972 for period one and P=0.1607 for period two).  Finally, total behavior scores 
for the two periods were compared between the surgical mice who received 
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buprenorphine and their non-surgical counterpart.  Surgery did not have any effect on 
the behavior of the mice who received buprenorphine (P=0.1636 for period one and 
P=0.2761 for period two). 
 Behavior scores for the three major categories were evaluated next, using an 
ANOVA table.  The mice that received surgery were assessed across the treatment 
groups first.  Physical condition scores for periods one and two were not affected by the 
administration of ketoprofen or buprenorphine when compared to a saline control 
(P=0.4845 and P=0.0973), and neither were the behavior scores (P=0.3651 and 
P=0.5326) or the posture scores (P=0.3515 and P=0.8745). 
 The mice that received ketoprofen, surgical and non-surgical control, were 
evaluated next.  Surgery did not have an effect on physical condition scores (P=0.7589 
for period 1 and P=0.6240 for period 2), the behavior score for period one (P=0.8516), 
or the posture scores (P=0.8700 for period 1 and P=0.1832 for period 2).  However, 
surgery did have an effect in the behavior score for period two (P < 0.05; see Figure 8). 
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Figure 8.  Summary of Behavior Scores by Period and Surgical Treatment, 
Ketoprofen Only.  Bar graph depicting the average behavior scores and standard 
deviations for the mice receiving ketoprofen, surgical (red) and non-surgical (blue), for 
periods 1 and 2.  Figure 8A shows the average scores for period 1 and no significant 
difference between the non-surgical control and surgical mice.  In Figure 8B, there is a 
significant difference between the higher score of the non-surgical control and the 
surgical mice. 
 
 The mice that received buprenorphine, surgical and non-surgical control, were 
evaluated next.  Surgery did have an effect on the physical condition score for period 
one (P < 0.05; see Figure 9).  However, the physical condition score for period two 
(P=0.1492), behavior scores for periods one and two (P=0.2802 and P=0.7569), and 
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posture scores for periods one and two (P=0.8879 and P=0.2589) did not show to be 
affected by presence or absence of surgery. 
 
 
 
Figure 9.  Summary of Physical Condition Scores by Period and Surgical 
Treatment, Buprenorphine Only.  Bar graph depicting the average physical condition 
scores and standard deviations for the mice receiving buprenorphine, surgical (red) and 
non-surgical (blue), for periods 1 and 2.  Figure 9A shows the average scores for period 
1 and a significant difference between the higher score of the non-surgical control and 
the surgical mice.  In Figure 9B, there is no significant difference between the non-
surgical control and the surgical mice for period 2. 
 
 One of the motivations behind this project was the theory that analgesics might 
relieve some of the post-operative stress on the mice and thereby allow for greater 
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numbers of embryos to implant and develop to term.  To test this theory, correlations 
between the post-operative behavior scores and whether or not a litter was born, as well 
as the number of pups born were evaluated. 
 Total behavior scores for periods one and two were tested against whether a litter 
was born with no significant results (P=0.6016 and P=0.4314), indicating that the 
behavior scale used in this experiment did not predict whether a mouse would carry a 
litter to term.  The total behavior scores were run again, this time against the number of 
pups born.  Again, however, there was no significant difference (P=0.2196 and 
P=0.4063), indicating that the behavior scale used did not predict how many pups would 
be born. 
 Scores for the major behavior categories were tested against whether a litter was 
born or not; however, none of the tests yielded significant results (P=0.6279 and 
P=0.2714 for physical condition; P=1.0000 and P=0.8877 for behavior; P=0.4706 and 
P=0.3314 for posture), once again showing that the behavior scale used did not predict 
whether a mouse would produce a litter. 
 Finally, scores for the major behavior categories were tested against the number 
of pups born, once again with no significant results (P=0.3418 and P=0.7493 for 
physical condition; P=0.4213 and P=0.5037 for behavior; P=0.7875 and P=0.6165 for 
posture), showing that the behavior scale used did not predict the number of pups born. 
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4.  CONCLUSIONS 
 The results from this study indicate that neither the NSAID-class drug ketoprofen 
nor the opioid-class drug buprenorphine have any significant effects on the number of 
mouse pups born or weaned, or the number of litters born, following embryo transfer 
procedures when compared to a saline control.  These results are not affected by the type 
of transfer procedure, uterine or oviduct, nor the condition of the embryos themselves, 
i.e. fresh or cryopreserved. 
 Further analysis of the data indicates that, within a range of weights, there is no 
correlation between the weight of the recipient female and her ability to carry the 
embryos to term, either in the number of pups born or whether she gave birth to a litter 
or not.  Results also indicate that the condition of the embryos (fresh or cryopreserved) 
do not have any bearing on the number of pups born or whether or not a litter was 
produced. 
 Post-operative behavior was affected only in two categories, and only between 
the non-surgical control mice and their surgical counterpart.  The ketoprofen mice 
differed significantly in their behavior scores for the second observation period, and the 
buprenorphine mice differed significantly in their physical condition scores for the first 
observation period.  It is possible that this difference is due to the fact that the non-
surgical mice were not as stimulated as the surgical mice, and so felt the effects of the 
anesthetic longer and more intensely than the surgical mice.  This phenomenon was 
remarked upon during the collection of the raw data; the observer mentioned that the 
non-surgical mice tended to be more lethargic and did not move around or groom 
50 
themselves as much as the surgical mice did.  The non-surgical mice did not appear to be 
in any discomfort; they simply appeared tired. 
 Apart from these two, the remainder of the analyses did not show any significant 
effect either between the three surgical treatments or between the non-surgical animals 
and their surgical counterpart in any of the categories studied.   
 In the original, ground-breaking work in embryo transfers accomplished by 
McLaren and Mitchie, the effects of surgery in general and self-styled traumatic surgery 
specifically were studied.  Their results indicated that the number of pups born to 
animals subjected to a surgical embryo transfer was not statistically significant when 
compared with non-surgical animals pregnant by natural means.  However, when 
subjected to traumatic surgical procedures, the rate of resorption of the transferred 
embryos increased dramatically when compared to animals receiving non-traumatic 
surgical procedures.  
 Although the type of surgery in that historic experiment was controlled for, 
sometimes there are problems that the investigator or surgeon cannot anticipate that 
result in a traumatic experience for the animal.  Use of analgesics in surgical procedures 
could forestall the discomfort and pain to the animal brought about by unforseen 
problems. 
 One of the more recent developments arising from the surgical technique 
pioneered by McLaren and Mitchie is the use of cryopreservation and embryo transfer to 
preserve and then reconstitute a genetic line.  Our experiment utilized both fresh and 
cryopreserved embryos with the two different surgical types.  Neither ketoprofen nor 
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buprenorphine had any noticeable effects on either embryo type.  Researchers who were 
reluctant to introduce another variable into an already complicated procedure such as 
reconstituting a preserved genetic line may wish to reconsider this position.  Using an 
analgesic, while not producing any significant increase in transfer efficiency, does not 
harm cryopreserved embryos. 
 Embryo transfer procedures are already very widespread and the number of 
people using these techniques on a daily basis is increasing rapidly, especially since it is 
now possible for researchers to create a genetic line of their own experimental design 
through gene targeting.  Embryo transfer is of particular import in this endeavor, since it 
is through this procedure that manipulated embryos are placed into the uterus of a 
recipient female and carried to term.  Without this surgical manipulation, the work gone 
into creating a transgenic or targeted mutant mouse stops at the embryonic level. 
 The study undertaken here did not include the possible effects of ketoprofen or 
buprenorphine on manipulated embryos of any kind, either transgenic embryos where 
purified DNA is injected into the pronucleus of a zygote, or targeted mutant embryos 
where ES cells with a DNA construct are injected into the donated blastocysts of 
superovulated mice.  Designing an experiment to examine such effects is highly 
recommended as a follow-up study, due to the increasing prevalence of such techniques 
and technology in laboratories today. 
 The selection of mouse strains in genetic manipulation procedures is critical; the 
eggs must be hardy enough to survive the manipulation procedure.  The embryo strain 
tested in this study, C57BL/6, was used as the donor strain because it is the most 
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common background strain employed when creating targeted mutant embryos, shown 
time and again to be one of the most hardy embryonic strains.  Unmanipulated embryos 
of this strain did not react adversely to the presence of ketoprofen or buprenorphine; 
however, testing of manipulated BL/6 embryos is encouraged as a follow-up study. 
 Other strains used in genetic manipulation procedures should be tested as well, 
first using unmanipulated embryos and then manipulated ones.  While C57BL/6 
embryos of 8-cell and blastocyst stages did not exhibit adverse effects with the 
introduction of ketoprofen or buprenorphine into the recipient mother, embryos of other 
strains might not fare as well. 
 Animals under stress can give confounding or unusable responses in 
experimental procedures.  Stress can come from a variety of sources, such as room 
environment, the scent of blood or animals in estrus or other noxious stimuli, pain, and 
experimental manipulation, to name a few.  Some of these stresses we cannot control for, 
but through the use of analgesics we can help ameliorate discomfort or pain in an 
experimental animal, and thereby decrease the amount of stress affecting it.   
 Opioids and NSAIDs were the two analgesic classes chosen for this experiment 
due to their actions at providing analgesia as well as their popularity in veterinary 
medicine.  NSAIDs are considered the most popular class of analgesics in use in small 
animal veterinary medicine.  Despite this popularity, however, neither drug type has 
been extensively studied for use in small rodents.  Very few clinical trials have been 
used to determine the effect of buprenorphine or ketoprofen on small rodents.  Paul 
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Flecknell has done tremendous work with these drugs and other analgesics in the rat, but 
the mouse has been sorely neglected (9). 
 In our work, we administered ketoprofen mixed with warmed saline immediately 
post-operatively, while buprenorphine was used one hour pre-operatively in order to 
give it time to reach its full analgesic potency.  Using the drugs in this way, our results 
show that they do not cause any adverse effects on the mouse in terms of physiology and 
behavior. 
 Many researchers are reluctant to use analgesics on experimental animals for 
multiple reasons.  The most common reason cited, and the one that led directly to this 
study, was the observation that older studies did not utilize analgesics.  They are 
concerned that the addition of an extra variable may confound or complicate 
experimental results and render their data null and void.  The work done in this study 
indicates that this is not a problem.  No differences were found in either the use of the 
NSAID ketoprofen or the opioid buprenorphine in our results when compared to a saline 
control. 
This study was designed to look at the effects of NSAID-class and opioid-class 
analgesics on embryo transfer procedures, specifically the effects on efficiency of 
transfer.  Although our results indicate there is no difference in transfer efficiency 
whether using an analgesic or not, further and more specific studies focusing on one of 
the many topics studied here are recommended.  Additional data on oviduct procedures, 
especially the effect of these analgesics on earlier-stage embryos, is an area of further 
recommended study.  Though the study of the effects of analgesics on post-operative 
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behavior was secondary to the larger picture of the effects on embryo transfer efficiency, 
behavior-specific studies are also recommended, with a more expanded and detailed 
method of determining behavior scores.   
 In conclusion, although further studies are recommended, based on our results we 
will continue to use analgesics in our transfer procedures.  Because analgesics do not 
appear to have any adverse effects on transfer efficiency rates, the adaptation of existing 
embryo transfer protocols to incorporate these drugs is a positive advance in animal 
health and comfort in comparative medicine. 
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